Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025)
Pulmonx's (LUNG) quarterly Amortizatization of Intangibles came in at $40000.0 in Q3 2025, down 90.12% year-on-year from $405000.0 in Q3 2024, and down 69.92% on a QoQ basis from $133000.0 in Q2 2025.
Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Amortizatization of Intangibles data on file, last reported at $40000.0 in Q3 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 90.12% year-over-year to $40000.0 in Q3 2025; TTM through Sep 2025 was $719000.0, a 55.12% decrease from a year earlier, with the FY2024 full-year figure at $1.6 million, up 57.66% from the prior year.
- Amortizatization of Intangibles for Q3 2025 stood at $40000.0, down from $133000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for LUNG reached as high as $478000.0 in Q2 2024 and fell as low as -$22000.0 in Q4 2021.
- Historically, Amortizatization of Intangibles has averaged $166578.9 across 5 years, with a median of $148000.0 in 2022.
- Across the five-year window, Amortizatization of Intangibles tumbled 700.0% in 2021 and jumped 11600.0% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$22000.0 in 2021, then soared by 772.73% to $148000.0 in 2022, then soared by 120.27% to $326000.0 in 2023, then increased by 4.29% to $340000.0 in 2024, then plunged by 88.24% to $40000.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $40000.0 in Q3 2025, $133000.0 in Q2 2025, and $206000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 40,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Mar 31, 2025 | 206,000.00 |
| Dec 31, 2024 | 340,000.00 |
| Dec 31, 2024 | 340,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 478,000.00 |
| Jun 30, 2024 | 478,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 234,000.00 |